Multiple Pathways Lead to Therapy Resistance in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is notoriously challenging to treat, primarily because nearly half of all patients eventually develop resistance to standard therapies. This therapeutic resistance...
















